<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02061904</url>
  </required_header>
  <id_info>
    <org_study_id>BMD&amp;BIG</org_study_id>
    <nct_id>NCT02061904</nct_id>
  </id_info>
  <brief_title>Bone Mineral Density Changes of the Acetabulum After Revision Hip Arthroplasty Using Bone Impaction Grafting</brief_title>
  <acronym>BMD&amp;BIG</acronym>
  <official_title>Prospective Exploratory Study:Bone Mineral Density Changes of the Acetabulum After Revision Hip Arthroplasty Using Bone Impaction Grafting</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rijnstate Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rijnstate Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective explorative study for the investigation of short-term and medium-term outcomes&#xD;
      regarding bone mineral density changes after revision hip arthroplasty making use of bone&#xD;
      impaction grafting. Outcome measurements will include objective and subjective clinical data,&#xD;
      complications and adverse events, radiographic data measurements recorded at several&#xD;
      postoperative intervals.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypothesis, open questions and specific aims of the project:&#xD;
&#xD;
      We believe that it is important to gain further insight in the process of bone graft&#xD;
      remodeling and the preservation of bone stock after bone impaction grafting.&#xD;
&#xD;
      Radiographs are far from conclusive and CT scan can not be repeated on regular intervals for&#xD;
      obvious reasons. Prospective follow-up of the BMD of the bone impaction area will contribute&#xD;
      to our further understanding. There is no literature available on BMD changes in the&#xD;
      acetabulum after bone impaction grafting.&#xD;
&#xD;
      From our recent experiences with earlier research on BMD in specific ROI in the femoral neck&#xD;
      we are motivated to further explore the potential of our DEXA technology and software in the&#xD;
      field revision hip arthroplasty.&#xD;
&#xD;
      We hypothesize that BMD changes in the bone impaction grafted acetabulum can be adequately&#xD;
      monitored with modern DEXA techniques.&#xD;
&#xD;
      Research Questions are:&#xD;
&#xD;
        1. Will bone impaction grafting of the acetabulum result in a well preserved/remodelled&#xD;
           bone stock within 2 years after revision hip arthroplasty?&#xD;
&#xD;
        2. Can changes in BMD be interpreted as representative for the process of bone remodelling&#xD;
           in the bone impacted area?&#xD;
&#xD;
           Study design&#xD;
&#xD;
           This trial as described in this protocol is a prospective explorative follow-up study&#xD;
           recording the clinical, radiographic data, and bone mineral density data at specific&#xD;
           time intervals (preoperative, within 2 weeks postoperative, at 3months, 6months, 1 year&#xD;
           and 2 years postoperative). The data will be collected using SPSS (version 20.)&#xD;
&#xD;
           Main objective:&#xD;
&#xD;
           To prospectively assess the BMD at short and medium time intervals in specific ROI as an&#xD;
           indicator for the process of bone remodelling and ossification of the bone impaction&#xD;
           graft after revision hip arthroplasty..&#xD;
&#xD;
           Secondary Objectives:&#xD;
&#xD;
           Clinical scores (SF-12, Oxford Hip score, VAS pain and VAS satisfaction) will be&#xD;
           obtained. Vigilant identification of Adverse Events (AEs) will be maintained throughout&#xD;
           the study. Mean changes in clinical scores, over time, will also be tested with repeated&#xD;
           measurement statistics. Because clinical success is not always indicative of&#xD;
           radiographic success and vice versa, correlations will be made.&#xD;
&#xD;
           Sample size:&#xD;
&#xD;
           Our study concerns an explorative study in twenty patients.&#xD;
&#xD;
           Study duration:&#xD;
&#xD;
           The expected duration of the study is approximately 3 years from the commencement of&#xD;
           subject enrollment. Subject enrollment is expected to take 1 year. All subjects will be&#xD;
           followed for at least two years after surgery until the last subject achieves two-years&#xD;
           follow-up.&#xD;
&#xD;
           Evaluation criteria&#xD;
&#xD;
           The study is designed to evaluate possible clinical, radiographic and bone densitometry&#xD;
           differences changes after revision hip arthroplasty.&#xD;
&#xD;
           Evaluation criteria at different follow-up intervals.&#xD;
&#xD;
           A Clinical:&#xD;
&#xD;
             -  the patient's own evaluation according to the Oxford Score, Dutch translation&#xD;
                validated&#xD;
&#xD;
             -  the patient's evaluation of his general health with the SF-12 score , license to&#xD;
                validated Dutch translation11&#xD;
&#xD;
             -  the patient's degree of pain and satisfaction with the prosthesis and the&#xD;
                procedure.&#xD;
&#xD;
           B Radiological:&#xD;
&#xD;
             -  X-ray evaluations of implant stability, migration, changing of cup or head angles,&#xD;
                radiolucent lines, loosening and osteolysis. X-Rays should preferably be digital,&#xD;
                at preoperative, 6 months, 1 year and 2 years.&#xD;
&#xD;
           C. DEXA bone density measurements&#xD;
&#xD;
           - Bone density measurements will be performed preoperative on the acetabulum on several&#xD;
           regions of interests (ROI's) including the bone impaction grafting area. Once this ROI's&#xD;
           of the acetabulum has been determined it can be digitalized and saved into the software,&#xD;
           subsequently this ROI can be transported 4 days postoperative and at 4 days&#xD;
           postoperative, 6 months, 1 year and 2 years.&#xD;
&#xD;
           - This method has been tested in our earlier resurfacing study and has proved to be&#xD;
           reliable and reproducable.&#xD;
&#xD;
           - An independent radiologist will do the measurements on the DEXA-scan&#xD;
&#xD;
           D Survival after revision hip arthroplasty with bone impaction grafting - According to&#xD;
           Kaplan Meiers survival rates.&#xD;
&#xD;
           E Complications and adverse events&#xD;
&#xD;
           - Early and late complications possibly associated with revision hip arthroplasty and&#xD;
           possible relationship with bone impaction grafting and surgical technique.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">January 2017</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bone mineral density changes</measure>
    <time_frame>24 months</time_frame>
    <description>Acetabular bone mineral density measurements after bone impaction grafting using DEXA, changes in density compared to baseline levels: at &lt; 2weeks postoperative, at 3, 6, 12 and 24 months postoperative</description>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Disorder of Bone Density and Structure, Unspecified</condition>
  <condition>Satisfaction</condition>
  <arm_group>
    <arm_group_label>Bone Mineral Density</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Bone mineral density measurement with &quot;intervention&quot; DEXA at the bone impaction graft site:&#xD;
DEXA: dual energy X-ray absorptiometry</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hip function</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Hip Function/mobility development:&#xD;
Harris Hip Score</description>
  </arm_group>
  <arm_group>
    <arm_group_label>pain experience</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Pain experiences after surgery in the hip joint VAS-pain</description>
  </arm_group>
  <arm_group>
    <arm_group_label>General Patients Health condition</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients health condition monitoring: intervention SF12:&#xD;
Short Form Health Survey 12</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention Satisfaction</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients satisfaction development after the intervention VAS-satisfaction</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>DEXA: dual energy X-ray absorptiometry</intervention_name>
    <description>Bone mineral density development measured with dual energy X-ray absorptiometry</description>
    <arm_group_label>Bone Mineral Density</arm_group_label>
    <other_name>Bone Mineral Density measurement</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Short Form Health Survey 12</intervention_name>
    <description>questionnaire for general health monitoring</description>
    <arm_group_label>General Patients Health condition</arm_group_label>
    <other_name>SF12</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>VAS-satisfaction</intervention_name>
    <description>questionnaire for intervention satisfaction monitoring</description>
    <arm_group_label>Intervention Satisfaction</arm_group_label>
    <other_name>Visual analoge Scale for satisfaction.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>VAS-pain</intervention_name>
    <description>questionnaire for pain monitoring</description>
    <arm_group_label>pain experience</arm_group_label>
    <other_name>visual analog scale for pain</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Harris Hip Score</intervention_name>
    <description>questionnaire for hip function monitoring</description>
    <arm_group_label>Hip function</arm_group_label>
    <other_name>HHS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. revision hip arthroplasty with acetabular defects eligible for bone impaction grafting&#xD;
&#xD;
          2. Diagnosis: acetabular osteolytic defects after primary total hip arthroplasty, planned&#xD;
             for revision hip arthroplasty with bone impaction grafting.&#xD;
&#xD;
          3. Patient is between 35 and 75 years old.&#xD;
&#xD;
          4. Patient is expected to recover completely.&#xD;
&#xD;
          5. Patient is willing and able to come to follow-up examinations.&#xD;
&#xD;
          6. Patient has signed an informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Infection of the hip joint or distant infection (may cause hematogenous spread to the&#xD;
             implant site)&#xD;
&#xD;
          2. Hip fractures&#xD;
&#xD;
          3. Patient is younger than 35 years or older than 75 years.&#xD;
&#xD;
          4. Patient is not willing and/or able to come to follow-up examinations&#xD;
&#xD;
          5. Patient has not signed an informed consent&#xD;
&#xD;
          6. Pregnancy&#xD;
&#xD;
        Relative contra-indications:&#xD;
&#xD;
        With regard to the patient's general health:&#xD;
&#xD;
          1. Metabolic disorders or medication (e.g. steroids) which may impair bone formation&#xD;
&#xD;
          2. Osteomalacia&#xD;
&#xD;
          3. Disorders of the immune system, caused by disease or immunosuppressive medication&#xD;
             which increase the risk of infection.&#xD;
&#xD;
          4. Poor prognosis for good wound healing: decubitus ulcer, end-stage diabetes, severe&#xD;
             protein deficiency and/or malnutrition&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>J v Susante, MD. PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rijnstate Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rijnstate Hospital</name>
      <address>
        <city>Arnhem</city>
        <state>Gelderland</state>
        <zip>6800WC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <reference>
    <citation>Smolders JM, Pakvis DF, Hendrickx BW, Verdonschot N, van Susante JL. Periacetabular bone mineral density changes after resurfacing hip arthroplasty versus conventional total hip arthroplasty. A randomized controlled DEXA study. J Arthroplasty. 2013 Aug;28(7):1177-84. doi: 10.1016/j.arth.2012.08.025. Epub 2012 Dec 6.</citation>
    <PMID>23219623</PMID>
  </reference>
  <reference>
    <citation>Smolders JM, Hol A, Rijnders T, van Susante JL. Changes in bone mineral density in the proximal femur after hip resurfacing and uncemented total hip replacement: A prospective randomised controlled study. J Bone Joint Surg Br. 2010 Nov;92(11):1509-14. doi: 10.1302/0301-620X.92B11.24785.</citation>
    <PMID>21037344</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <study_first_submitted>February 9, 2014</study_first_submitted>
  <study_first_submitted_qc>February 11, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 13, 2014</study_first_posted>
  <last_update_submitted>October 3, 2017</last_update_submitted>
  <last_update_submitted_qc>October 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rijnstate Hospital</investigator_affiliation>
    <investigator_full_name>Job van Susante</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bone Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

